XML 237 R77.htm IDEA: XBRL DOCUMENT v3.10.0.1
Stockholders' Equity - Narrative (Details)
 12 Months Ended
Apr. 03, 2017
USD ($)
$ / shares
shares
May 09, 2016
USD ($)
$ / shares
shares
Dec. 31, 2018
USD ($)
vote
$ / shares
shares
Dec. 31, 2017
USD ($)
$ / shares
shares
Dec. 31, 2016
USD ($)
$ / shares
shares
Nov. 02, 2018
USD ($)
May 31, 2018
shares
Subsidiary, Sale of Stock [Line Items]              
Common stock, votes entitled per share | vote     1        
Preferred stock, shares issued (in shares)     0 0      
Repurchase of common stock (in shares)     466,519        
Treasury stock (in shares)     466,519 0      
Shares withheld for tax purposes and retired (in shares)     28,291 65,952      
Grants in the period (in shares)     1,196,575 217,341 79,240    
Grants in the period (USD per share) | $ / shares     $ 12.58 $ 10.69 $ 4.36    
Period for recognition     3 years 9 months 7 days        
Vested (in shares)     150,280 612,463 351,855    
Nonvested awards, compensation costs not yet recognized | $     $ 13,600,000        
Total compensation cost attributable to shares awarded | $     3,100,000 $ 2,800,000 $ 1,800,000    
Shares issued in acquisition of business (in shares)       1,882,058      
Share consideration given for Tealstone acquisition (in shares) | $     0 $ 17,061,000 0    
Net proceeds from stock issued | $     0 0 19,142,000    
Warrants issued to lenders | $     0 3,500,000 0    
Restricted Stock              
Subsidiary, Sale of Stock [Line Items]              
Total compensation cost attributable to shares awarded | $     $ 509,988 $ 353,000 $ 250,000    
Restricted Stock | Minimum              
Subsidiary, Sale of Stock [Line Items]              
Period for recognition     2 years        
Restricted Stock | Maximum              
Subsidiary, Sale of Stock [Line Items]              
Period for recognition     4 years        
Restricted Stock | Key Employees              
Subsidiary, Sale of Stock [Line Items]              
Grants in the period (in shares)     1,147,285 180,542 20,000    
Grants in the period (USD per share) | $ / shares     $ 12.62 $ 10.92 $ 4.78    
Restricted Stock | Non Employee Director              
Subsidiary, Sale of Stock [Line Items]              
Period for recognition     1 year        
Total compensation cost attributable to shares awarded | $     $ 63,745        
Plan 2001              
Subsidiary, Sale of Stock [Line Items]              
Number of shares authorized for grant (in shares)     1,900,000        
Plan 2018              
Subsidiary, Sale of Stock [Line Items]              
Number of shares authorized for grant (in shares)             1,800,000
Long-term Incentive Plan              
Subsidiary, Sale of Stock [Line Items]              
Vested (in shares)       47,947      
Forfeited in the period (in shares)     0   29,781    
Long-term Incentive Plan | Performance Shares              
Subsidiary, Sale of Stock [Line Items]              
Vested (in shares)       15,982      
D.A. Davidson and Co.              
Subsidiary, Sale of Stock [Line Items]              
Share price (USD per share) | $ / shares   $ 4          
Share price, net (USD per share) | $ / shares   $ 3.77          
Net proceeds from stock issued | $   $ 19,100,000          
Tealstone              
Subsidiary, Sale of Stock [Line Items]              
Shares issued in acquisition of business (in shares) 1,882,058     1,882,058      
Share consideration given for Tealstone acquisition (in shares) | $ $ 17,061,000            
Warrants to the Lenders Under the Loan Agreement              
Subsidiary, Sale of Stock [Line Items]              
Share price (USD per share) | $ / shares $ 8.88            
Warrants issued to lenders | $ $ 3,500,000     $ 3,500,000      
Warrants to the Lenders Under the Loan Agreement | Loan and Security Agreement              
Subsidiary, Sale of Stock [Line Items]              
Warrants, term 5 years            
Number of shares issued if warrants are called (in shares) 1,000,000            
Warrant exercise price (USD per share) | $ / shares $ 10.25            
Common Stock              
Subsidiary, Sale of Stock [Line Items]              
Stock repurchase program, authorized amount | $           $ 2,000,000  
Stock issued in equity offering, net of expense (in shares)   5,175,000     5,175,000    
Common Stock | Plan 2018              
Subsidiary, Sale of Stock [Line Items]              
Number of shares available for grant (in shares)     957,392